Clinical Trials Sponsored by Autophagy Sciences, Inc.

Total 1408 results

Power Life Sciences Inc.

Not yet recruiting

Taking a Look at Patient Experiences In Rectal Cancer Clinical Trials

Rectal Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia Patients

Chronic Lymphocytic Leukemia

United States
Power Life Sciences Inc.

Not yet recruiting

Examination of Trends in Colorectal Cancer Patients' Clinical Study Experiences

Colorectal Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Examining Clinical Research Participation for Substance Abuse Disorder Patient

Substance Abuse Disorder

United States
Power Life Sciences Inc.

Not yet recruiting

Examination of Trends in Multiple Myeloma Trial Patient Experiences

Multiple Myeloma
Power Life Sciences Inc.

Not yet recruiting

Navigating the Clinical Trial Process for Hepatocellular Carcinoma

Hepatocellular Carcinoma
Power Life Sciences Inc.

Not yet recruiting

Studying the Clinical Research Experiences of Patients With PTSD

PTSD
Power Life Sciences Inc.

Not yet recruiting

Analyzing Clinical Research Participation of Patients With Spinal Cord Injury

Spinal Cord Injuries
Power Life Sciences Inc.

Not yet recruiting

Studying the Clinical Trial Experiences of Patients With Mesothelioma

Mesothelioma
Power Life Sciences Inc.

Not yet recruiting

Discovering Factors in Head and Neck Cancer Patients' Clinical Study Experiences

Head and Neck Cancer
Surgical Information Sciences Inc.

Recruiting

Visualization of the STN and GPi for DBS (VISION)

Parkinson Disease | Deep Brain Stimulation

United States
Power Life Sciences Inc.

Not yet recruiting

Examining Clinical Trial Participation for Small Cell Lung Cancer Patients

Small Cell Lung Cancer
Power Life Sciences Inc.

Not yet recruiting

Determining Clinical Trial Experiences of Lung Cancer Patients

Lung Cancer
Power Life Sciences Inc.

Not yet recruiting

Discovering Factors in Metastatic Breast Cancer Patients' Clinical Trial Experiences

Metastatic Breast Cancer
Alpine Immune Sciences, Inc.

Recruiting

An Open-label Study of Povetacicept in Subjects With Autoimmune Cytopenias (RUBY-4)

Immune Thrombocytopenia | Idiopathic Thrombocytopenic Purpura | Cold Agglutinin Disease | Warm Autoimmune Hemolytic Anemia

United States, Canada, Australia, Turkey, United Kingdom
Power Life Sciences Inc.

Not yet recruiting

Finding Patterns In Clinical Trial Experiences of Patients With Eczema

Eczema
Power Life Sciences Inc.

Not yet recruiting

Evaluating Patient Experiences in Skin Care Clinical Studies

Skin Care
Power Life Sciences Inc.

Not yet recruiting

Investigating Clinical Trial Participation for Acne Patients

Acne
Alpine Immune Sciences, Inc.

Recruiting

An Open-label Study of Povetacicept (ALPN-303) in Autoimmune Kidney Diseases (RUBY-3)

Lupus Nephritis | Immunoglobulin A Nephropathy | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Membranous Nephropathy

United States, Australia, Korea, Republic of, Austria, Norway, Spain, United Kingdom
Power Life Sciences Inc.

Not yet recruiting

Examining Patterns in the Involvement of Gastric Bypass Patients in Clinical Studies

Gastric Bypass | Weight Loss Surgery
Power Life Sciences Inc.

Not yet recruiting

Determining Patterns In Trial Experiences of Parkinson's Disease Patients

Parkinson Disease
TransThera Sciences (Nanjing), Inc.

Not yet recruiting

TT-00973-MS Tablets in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Power Life Sciences Inc.

Not yet recruiting

Assessment of Clinical Trial Experiences of Alzheimer's Disease Patients

Alzheimer Disease
TriSalus Life Sciences, Inc.

Recruiting

Pressure Enabled Intrapancreatic Delivery of SD-101 With Checkpoint Blockade for Locally Advanced Pancreatic Adenocarcinoma

Locally Advanced Pancreatic Adenocarcinoma

United States
Power Life Sciences Inc.

Not yet recruiting

Assessing Clinical Trial Experiences of Patients With Osteosarcoma

Osteosarcoma
Power Life Sciences Inc.

Not yet recruiting

Determining Patterns In Trial Experiences of Diabetic Neuropathy Patients

Diabetic Neuropathies | Diabetic Neuropathy Peripheral
Power Life Sciences Inc.

Not yet recruiting

Clinical Trial - Analyzing Participation Experiences Of Amyotrophic Lateral Sclerosis Patients

Amyotrophic Lateral Sclerosis | ALS
Power Life Sciences Inc.

Not yet recruiting

Neoadjuvant Immunotherapy in Advanced NSCLC

Lung Cancer, Non-small Cell

United States
Kezar Life Sciences, Inc.

Recruiting

KZR-261 in Subjects With Advanced Solid Malignancies

Advanced/Metastatic Solid Tumor

United States
Alpine Immune Sciences, Inc.

Active, not recruiting

ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus (Synergy)

Systemic Lupus Erythematosus

United States, France, Hungary, Poland, Puerto Rico, Spain, Taiwan
TransThera Sciences (Nanjing), Inc.

Completed

Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

Sarcoma | Gastric Cancer | Prostate Cancer | Cholangiocarcinoma | Bladder Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Small-cell Lung Cancer | Thyroid Cancer | Gallbladder Cancer | HER2-negative Breast Cancer

United States
Kezar Life Sciences, Inc.

Completed

A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis (MISSION)

Systemic Lupus Erythematosus | Lupus Nephritis

United States, Australia, Mexico, Russian Federation, Colombia, Peru, Poland, Ukraine
TransThera Sciences (Nanjing), Inc.

Active, not recruiting

Safety of TT-00420 (Tinengotinib) Monotherapy in Patients With Advanced Solid Tumors and Triple Negative Breast Cancer

Advanced Solid Tumors | Triple Negative Breast Cancer

United States, China
TransThera Sciences (Nanjing), Inc.

Completed

Relative Bioavailability Study and Food Effect Study of TT-00420 (Tinengotinib) Capsule and Tablet Formulations in Healthy Volunteers

Healthy

United States
TriSalus Life Sciences, Inc.

Active, not recruiting

Pressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver Tumors

Hepatocellular Carcinoma | Intrahepatic Cholangiocarcinoma

United States
Alpine Immune Sciences, Inc.

Terminated

ALPN-101 in Steroid-resistant or Steroid-refractory Acute GVHD (Balance)

Graft Vs Host Disease

United States
ReAlta Life Sciences, Inc.

Completed

A Phase 1 SAD/MAD Study of RLS-0071 in Healthy Volunteers in Support of a COVID-19 Development Program

Healthy Volunteer

Canada
Surgical Information Sciences Inc.

Completed

Accuracy Evaluation for SIS Software-based Visualization of Anatomical Brain Structures

Software Evaluation for Visualizing Anatomical Structures That Are Not Typically Identified on Clinical MR Images
MSI Methylation Sciences, Inc.

Completed

Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

United States
Human Genome Sciences Inc.

Completed

A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1

Hepatitis C, Chronic

Canada, Australia, Israel, Germany, Czech Republic, France, Poland, Romania
Human Genome Sciences Inc.

Completed

Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States, Canada, Australia, India
Human Genome Sciences Inc.

Terminated

A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01

Rheumatoid Arthritis

United States, Poland
Human Genome Sciences Inc.

Completed

Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

United States
Human Genome Sciences Inc.

Completed

Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Lymphoma, Non-Hodgkin

United States
Human Genome Sciences Inc.

Completed

A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3

Chronic Hepatitis C

Canada
Human Genome Sciences Inc.

Withdrawn

Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis

Ulcerative Colitis
Afexa Life Sciences Inc

Completed

A Randomized, Double-blind, Placebo-controlled Study on the Efficacy and Safety of CVT-E002 in the Treatment of Upper Respiratory Tract Infections in a Pediatric (3-11 Years) Population

Upper Respiratory Tract Infections

Canada
Oculus Innovative Sciences, Inc.

Completed

Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults

Pruritus | Atopic Dermatitis

United States
Afexa Life Sciences Inc

Completed

LIP-01 in Hypercholesterolemia

Hypercholesterolemia

Canada, United States
Advanced Life Sciences, Inc.

Completed

Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia (CAP)

Pneumonia

United States

Clinical Trials Sponsored by Autophagy Sciences, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations